30-Days Approval for all CARL. SETs

May 12, 2026

Maximizing Clinical Continuity in Patient Support

In clinical practice, time is of the essence. While a 7-day usage period used to be the industry standard for reperfusion sets, modern technology has advanced.

Our sets are fully CE-certified and approved for 30 days of continuous use. Both the CARL ONE SET and the CARL RESET offer strategic value to your department and, thanks to their extended usage times, positively impact patient safety and treatment efficiency.

Why the 30-day lifespan matters for clinical teams and patients:

More safety & flexibility during transport

Patient transport is a high-risk phase, whether within the hospital or using specialized transport vehicles. A 30-day usage period gives your team maximum flexibility. The patient remains safely connected to a proven system, ensuring clinical care during the most delicate phases of transport.

Reduced risk of complications

The risk of complications increases with every set change and every brief interruption in treatment. Thanks to the approved 30-day application period, we significantly reduce the number of required changes to our reperfusion sets. This creates a more stable environment for the patient and a safer workflow for clinical staff.

Lower resource consumption per patient

Hospital budgets and the use of available resources are under constant scrutiny these days. For patients who require treatment lasting several weeks, for example, our 30-day approval allows us to reduce the number of sets used per case. This leads to lower material consumption and reduces the workload of the nursing and perfusion teams.

Extending the usage period to 30 days represents a significant advancement in terms of procedural safety and cost-effectiveness for all CARL SETs. By fully utilizing the approved usage period of our sets, you ensure maximum clinical continuity with minimal effort.

For more information please contact us via:
sales@resuscitec.de